REQUEST A DEMO
Total
USD $0.00
Search more companies

Mapo Pharma S.R.O. (Czech Republic)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Mapo Pharma S.R.O. Profile Updated: December 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Mapo Pharma S.R.O. is an enterprise in Czech Republic, with the main office in Olomouc. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. The enterprise was incorporated on February 24, 2014. 50 - 99 (2024) employees currently work for Mapo Pharma S.R.O.. The company’s latest financial report indicates a net sales revenue increase of 46.22% in 2022. Its’ total assets recorded a growth of 30.19%. The net profit margin of Mapo Pharma S.R.O. decreased by 4.57% in 2022.

Headquarters
tr. Kosmonautu 1338/1
Olomouc; Olomoucky; Postal Code: 77900

Contact Details: Purchase the Mapo Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Mapo Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Mapo Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Mapo Pharma S.R.O. report to view the information.
Incorporation Date:
February 24, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Mapo Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
46.22%
Total operating revenue
45.92%
Operating profit (EBIT)
-36.92%
EBITDA
-34.97%
Net Profit (Loss) for the Period
-20.05%
Total assets
30.19%
Total equity
-18.21%
Operating Profit Margin (ROS)
-6.85%
Net Profit Margin
-4.57%
Return on Equity (ROE)
-0.98%
Debt to Equity Ratio
71.93%
Quick Ratio
0.07%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?